Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disorder with complex biology and significant clinical heterogeneity. Many preclinical and early phase ALS clinical trials have yielded promising results that could not be replicated in larger phase 3 confirmatory trials. One re...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Namita A., Berry, James D., Windebank, Anthony, Staff, Nathan P., Maragakis, Nicholas J., van den Berg, Leonard H., Genge, Angela, Miller, Robert, Baloh, Robert H., Kern, Ralph, Gothelf, Yael, Lebovits, Chaim, Cudkowicz, Merit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Invited Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496557/
https://www.ncbi.nlm.nih.gov/pubmed/31899540
http://dx.doi.org/10.1002/mus.26801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496557/
https://www.ncbi.nlm.nih.gov/pubmed/31899540
http://dx.doi.org/10.1002/mus.26801

Ejemplares similares